Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceCombined Modality TherapyMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBlood CellsBone Marrow ExaminationImmunosuppressive AgentsTreatment OutcomeRemission InductionTime FactorsHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionImmunosuppressionStem Cell TransplantationLymphocyte DepletionLeukocyte TransfusionAcute DiseaseLymphoma, Non-HodgkinHeart TransplantationColony-Forming Units AssaySevere Combined ImmunodeficiencyT-LymphocytesChimeraMyelodysplastic SyndromesSurvival AnalysisHLA AntigensRetrospective StudiesLeukocyte CountLung TransplantationHematologic DiseasesCyclosporineActuarial AnalysisBone DensityLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCell DifferentiationCarmustinePancytopeniaOrgan TransplantationGraft vs Tumor EffectFollow-Up StudiesSpleenCytarabineGraft vs Leukemia EffectSurvival RateBlood Cell CountCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorMice, Inbred BALB CFlow CytometryBone ResorptionMelphalanErythrocytesDisease-Free SurvivalEtoposideLymphomaCells, CulturedMultiple MyelomaAntigens, CD34Fatal OutcomeGranulocytesMice, KnockoutPrognosisHodgkin Disease